Key result
Contemporary CABG-BITA risk score predicts 20-year survival with ~73% discriminatory accuracy.
Why the study?
This study aimed to externally validate a contemporary nomogram for predicting long-term survival after isolated CABG with bilateral internal thoracic artery grafting.
Does a contemporary nomogram accurately predict long-term survival in patients who undergo CABG-BITA?
Cohort (n=2,846)
No
Does a contemporary nomogram accurately predict long-term survival in patients who undergo CABG-BITA?
The externally validated risk score provides a practical and generalizable tool for clinicians and cardiac surgeons to identify patients who are most likely to derive a long-term survival benefit from CABG-BITA.
The CABG-BITA risk score shows moderate discrimination for long-term survival; leaves open prospective validation before guiding clinical decisions.
Background: This study aimed to verify the external validation of a contemporary nomogram in predicting long-term survival after an isolated coronary artery bypass with bilateral internal thoracic artery grafting (CABG-BITA). Methods: Consecutive patients who underwent CABG-BITA at a single center were included in the study. All the predictors of the original risk score (age, diabetes mellitus, chronic obstructive pulmonary disease, congestive heart failure, chronic renal failure, old myocardial infarction, ejection fraction, intra-aortic balloon pump and peripheral arterial disease) were available for analysis. Results: Among the 2846 consecutive patients, a total of 1176 (41.3%) deaths were recorded during the 31,383 patient years of follow-up. The median EuroSCORE II was 2.35, and the median follow-up was 11.1 years. The risk score showed 72.7% overall discriminatory ability as measured by Harrell’s concordance statistic. It showed satisfactory calibration at 10, 15 and 20 years of follow-up. The risk score showed a time-varying nonlinear effect, and accordingly, adjusted long-term survival predictions were calculated. There were subgroups (scores < 50 points) with favorable 20-year survival rates ranging from 77% to 60%. Higher risk subgroups (scores > 90 points) showed poor 20-year survival rates ranging from 22% to 4%. Conclusions: The validated risk score represents a useful algorithm for the detection of patients who could benefit after CABG-BITA with respect to long-term survival. Although further multi-center studies are required worldwide to reveal the usefulness of this score in the clinical setting, its wide adoption may act as a motivation for cardiac surgeons resulting in higher numbers of CABG-BITA procedures.
No takes yet. Share an insight, caveat, or question.
Toumpoulis et al. (2022) conducted a cohort in Coronary artery disease requiring isolated CABG-BITA (n=2,846). Ziv-Baran CABG-BITA long-term survival risk score was evaluated on Discriminatory ability (Harrell's concordance statistic) for all-cause mortality (Harrell's C-statistic 72.7%). The contemporary CABG-BITA risk score demonstrated a 72.7% overall discriminatory ability and satisfactory calibration for predicting long-term survival up to 20 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: